All questions

Understand the offer

Has the FDA approved ipamorelin?

No approval is the starting point. A code, a prescription or a badge cannot stand in for it.

No approved use

On October 1, 2026, the FDA records checked for ipamorelin showed no approved medicine.

A drug label means the full medical information about a product, including its uses and warnings.

As of that date, it also has no drug label reviewed by the FDA.

Ask the clinician—the doctor or other health professional assessing you—to name the exact product. Ask what evidence supports its use and what rules allow it to be supplied.

A drug code is a record, not a review

As of October 1, 2026, the FDA drug-code list has entries for ipamorelin as a raw ingredient. That means material used to make a medicine, rather than a finished medicine for a patient.

The FDA says a National Drug Code, or NDC, does not show that a product has approval.

If a sales page points to a code, ask for the actual approval record.

Check what “registered” refers to

As of September 2026, federal rules say a business registering with the FDA has not gained approval for its drugs. Registration alone does not allow it to sell those drugs.

Ask which business is registered and whether it would make your medicine. If it would make the medicine to order, ask which ingredient rules allow that.

At the end of this chapter

Evidence notes

Ipamorelin record checked as of October 1, 2026.

Care-access notes checked as of September 2026.